5-N-tert-butyl-2-(3-chloro-4-ethylphenyl)spiro[4,7-dihydropyrazolo[1,5-a]pyrazine-6,1'-cyclopropane]-3,5-dicarboxamide
C22H28ClN5O2 — CID 118087438
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-N-tert-butyl-2-(3-chloro-4-ethylphenyl)spiro[4,7-dihydropyrazolo[1,5-a]pyrazine-6,1'-cyclopropane]-3,5-dicarboxamide
5-N-tert-butyl-2-(3-chloro-4-ethylphenyl)spiro[4,7-dihydropyrazolo[1,5-a]pyrazine-6,1'-cyclopropane]-3,5-dicarboxamide (PubChem CID 118087438) has the molecular formula C22H28ClN5O2 and a molecular weight of 429.95 g/mol. Its IUPAC name is 5-N-tert-butyl-2-(3-chloro-4-ethylphenyl)spiro[4,7-dihydropyrazolo[1,5-a]pyrazine-6,1'-cyclopropane]-3,5-dicarboxamide.
Molecular Properties
| Compound Name | 5-N-tert-butyl-2-(3-chloro-4-ethylphenyl)spiro[4,7-dihydropyrazolo[1,5-a]pyrazine-6,1'-cyclopropane]-3,5-dicarboxamide |
|---|---|
| PubChem CID | 118087438 |
| Molecular Formula | C22H28ClN5O2 |
| Molecular Weight | 429.95 g/mol |
| Exact Mass | 429.19 |
| IUPAC Name | 5-N-tert-butyl-2-(3-chloro-4-ethylphenyl)spiro[4,7-dihydropyrazolo[1,5-a]pyrazine-6,1'-cyclopropane]-3,5-dicarboxamide |
| SMILES | CCc1ccc(-c2nn3c(c2C(N)=O)CN(C(=O)NC(C)(C)C)C2(CC2)C3)cc1Cl |
| InChI | InChI=1S/C22H28ClN5O2/c1-5-13-6-7-14(10-15(13)23)18-17(19(24)29)16-11-27(20(30)25-21(2,3)4)22(8-9-22)12-28(16)26-18/h6-7,10H,5,8-9,11-12H2,1-4H3,(H2,24,29)(H,25,30) |
| InChIKey | YUFVSRISCYCYHK-UHFFFAOYSA-N |
| XLogP | 3.72 |
| TPSA | 93.25 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 429.95 |
| LogP ≤ 5 | 3.72 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118087438 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.